Biotech grants in Canada

Between cycles

Funds Quebec for-profit companies leading collaborative R&D projects with universities and research centres to develop innovative products or processes.

Between cycles

Funds student entrepreneur placements with shared support models and commercialization.

Between cycles

Supports teams connecting academia and industry to move ideas into practical outcomes.

Between cycles

Funds public-private genomics R&D projects up to CAD 2 million in which Canadian academic researchers partner with for-profit industry receptors to apply genomics outcomes to commercial needs.

Between cycles

Funds early-career Parkinson's disease researchers at United States and Canada institutions through independent investigator support.

Between cycles

Supports Quebec small firms expanding into Europe by funding export-market projects and international business development.

Between cycles

Funds career transitions for underrepresented clinician scientists in Canada to strengthen real-world implementation.

Between cycles

Funds commercialization pathways for genomic tools for pulse and cereal crop improvement through Canadian crop innovation.

Closed

Funds exploratory studies reimagining acute care to improve treatment pathways.

Closed

Funds joint India-Canada industrial R&D projects with a grant up to INR 1.5 crore per project.

Closed

Awards cash and in-kind prizes to Ontario life-science innovators who pitch a plan.

Discontinued

Funds recurring operating grants for priority Canadian health research collaborations.

Discontinued

Funds team-based health grants tackling national and international priorities to strengthen real-world implementation.

Open

Funds a €15M project that turns microbiome signals into a test for spotting cancer risk years ahead of any symptoms.

Open

Funds a €5M programme that pairs EU and Associated Country research institutions with Ukrainian cancer centres for joint training and staff exchanges.

Open

Funds up to four €8-9M grants for teams building AI-driven digital models of a patient's cancer to predict how it develops and guide personalised treatment.

Open

Funds three pragmatic clinical trials, €7-8M each, testing existing cancer immunotherapies in real-world care for patients whose disease resists treatment.

Open

Funds rare-disease research calls, clinical trial networks and shared data for ERDERA's second phase — open only to the existing coordinator.

Open

Funds one consortium to build a certified micro-credentials programme teaching entrepreneurship and innovation to health and life-science students.

Open

Funds €9M research consortia that map, monitor and identify deep-sea species and habitats to guide EU and global ocean protection targets.

Open

Funds €5M lump-sum projects that build sensor and lab-based methods to map, test and protect Europe's groundwater ecosystems.

Open

Funds two €4M projects for European consortia building bio-based products and studying whether people will actually adopt them.

Open

Funds research consortia developing the pre-normative science behind future standards for bio-based chemicals, polymers and other bio-based products.

Open

Funds three €4M lump-sum grants for industrial and environmental biotech — synthetic biology, gene editing, biofoundries — not health biotech or biofuels.